Ensign Peak Advisors, Inc Biogen Inc. Transaction History

Ensign Peak Advisors, Inc

$56.1 Billion
Q3 2024

A detailed history of Ensign Peak Advisors, Inc transactions in Biogen Inc. stock. As of the latest transaction made, Ensign Peak Advisors, Inc holds 24,111 shares of BIIB stock, worth $3.69 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

24,111

Previous 34,581 30.28%

Holding current value

$3.69 Million

Previous $8.02 Million 41.7%

% of portfolio

0.01%

Previous 0.01%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $1.98 Million - $2.48 Million	-10,470 Reduced 30.28%	24,111 $4.67 Million
Q2 2024 Aug 13, 2024	BUY	$190.52 - $236.72 $1.43 Million - $1.78 Million	7,505 Added 27.72%	34,581 $8.02 Million
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $12.2 Million - $15.4 Million	-57,387 Reduced 67.94%	27,076 $5.84 Million
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $28.9 Million - $34.8 Million	-130,009 Reduced 60.62%	84,463 $21.9 Million
Q3 2023 Nov 13, 2023	SELL	$253.3 - $285.89 $30.6 Million - $34.5 Million	-120,836 Reduced 36.04%	214,472 $55.1 Million
Q2 2023 Aug 14, 2023	BUY	$275.25 - $318.06 $1.9 Million - $2.2 Million	6,915 Added 2.11%	335,308 $95.5 Million
Q1 2023 May 15, 2023	BUY	$256.56 - $292.34 $25.3 Million - $28.8 Million	98,583 Added 42.9%	328,393 $91.3 Million
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $39.7 Million - $48.2 Million	157,068 Added 215.92%	229,810 $63.6 Million
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $7.8 Million - $10.8 Million	40,076 Added 122.68%	72,742 $19.4 Million
Q2 2022 Aug 12, 2022	SELL	$187.54 - $223.02 $7.01 Million - $8.34 Million	-37,400 Reduced 53.38%	32,666 $6.66 Million
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $2.02 Million - $2.54 Million	10,415 Added 17.46%	70,066 $14.8 Million
Q4 2021 Feb 11, 2022	SELL	$223.92 - $287.77 $13.2 Million - $17 Million	-59,105 Reduced 49.77%	59,651 $14.3 Million
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $7.02 Million - $9.15 Million	-24,794 Reduced 17.27%	118,756 $33.6 Million
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $7.02 Million - $11.2 Million	27,117 Added 23.29%	143,550 $49.7 Million
Q1 2021 May 12, 2021	SELL	$242.95 - $284.63 $6.26 Million - $7.33 Million	-25,768 Reduced 18.12%	116,433 $32.6 Million
Q4 2020 Feb 12, 2021	SELL	$236.26 - $355.63 $238,150 - $358,475	-1,008 Reduced 0.7%	142,201 $34.8 Million
Q3 2020 Nov 12, 2020	SELL	$264.77 - $305.71 $11.5 Million - $13.3 Million	-43,424 Reduced 23.27%	143,209 $40.6 Million
Q2 2020 Aug 12, 2020	SELL	$258.66 - $342.55 $23.8 Million - $31.6 Million	-92,105 Reduced 33.04%	186,633 $49.9 Million
Q1 2020 May 11, 2020	BUY	$268.85 - $341.04 $654,918 - $830,773	2,436 Added 0.88%	278,738 $88.2 Million
Q4 2019 Feb 14, 2020	BUY	$220.06 - $304.07 $60.8 Million - $84 Million	276,302 New	276,302 $82 Million

Others Institutions Holding BIIB

# of Institutions

1,035

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ensign Peak Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Ensign Peak Advisors, Inc with notifications on news.

Account

Ensign Peak Advisors, Inc Biogen Inc. Transaction History